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The Vav family of proteins are guanine nucleotide exchange
factors (GEFs) for the Rho family of GTPases, which regulate
various cellular functions, including T-cell activation. They
contain a catalytic Dbl homology (DH) domain that is invariably
followed by a pleckstrin homology (PH) domain, which is often
required for catalytic activity. Vav proteins are the first GEFs for
which an additional C1 domain is required for full biological
activity. Here, we present the structure of a Vav1 fragment
comprising the DH–PH–C1 domains bound to Rac1. This
structure shows that the PH and C1 domains form a single
structural unit that packs against the carboxy-terminal helix of
the DH domain to stabilize its conformation and to promote
nucleotide exchange. In contrast to previous reports, this
structure shows that there are no direct contacts between the
GTPase and C1 domain but instead suggests new mechanisms for
the regulation of Vav1 activity.
Keywords: C1 domain; exchange factor; GTPase; Vav1; X-ray
crystallography
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INTRODUCTION
Vav1 is a guanine nucleotide exchange factor (GEF) for the Rho
family of GTPases, and has been shown to be crucial in T-cell
development and activation (Tybulewicz, 2005). Analysis of
Vav1-deficient T cells has shown that Vav1 transduces T-cell
antigen receptor signals to several downstream pathways and it
has been suggested that some of these might depend on the GEF
activity of Vav1, whereas others depend on the function of Vav1
as an adapter protein (Tybulewicz et al, 2003).
The primary structure of Vav1 shows that the protein contains
eight domains (Fig 1A; Tybulewicz, 2005). Vav1, in common with
many GEFs for the Rho family of GTPases (RhoGEFs), contains a
conserved Dbl homology (DH) domain, which is responsible for
catalysing nucleotide exchange (Crespo et al, 1997; Han et al,
1997). As seen in most RhoGEFs, the DH domain is flanked by a
pleckstrin homology (PH) domain (Rossman et al, 2005). In
addition, there is a calponin homology (CH) domain, and an
acidic (Ac) region to the amino-terminal and a C1 domain to
the carboxy-terminal side of the DH/PH module. Finally, the
C terminus of the protein contains one SH2 and two SH3 domains.
It has been proposed that the CH–C1 part of Vav1 is involved in
regulating exchange activity, whereas the SH3/SH2/SH3 domains
might have adapter function.
The GEF activity of Vav1 is regulated by several mechanisms.
Phosphorylation of Tyr174 within the Ac region results in an
increase in GEF activity (Crespo et al, 1997; Han et al, 1997;
Lopez-Lago et al, 2000). A solution structure of the DH domain of
Vav1, including residues 170–189 of the Ac region, shows that
Tyr174 lies within an a-helix that binds to part of the GTPase
interaction site, thereby occluding access to the GTPase
(Aghazadeh et al, 2000). Phosphorylation of Tyr174 causes
dissociation of this helix from the DH domain, thereby relieving
the autoinhibition. The CH domain has also been implicated in an
autoinhibitory function, as deletion of this domain results in
increased exchange activity (Zugaza et al, 2002). It has been
proposed that the CH domain might bind directly to the C1
domain and thereby hold the Vav1 protein in an inactive ‘closed’
conformation, in which the CH–C1 interaction helps to stabilize
the inhibitory Tyr174–DH interaction. Activation of Vav1 would
then be achieved by a conformational change leading to an ‘open’
conformation in which the DH domain is no longer occluded.
Support for such a model has come from single-particle electron
microscopy of Vav3 (Llorca et al, 2005).
The PH domains of DH-containing RhoGEFs seem to have
diverse functions (Rossman et al, 2005). In some cases, they
participate directly in binding to the GTPase, and in other cases
they might bind to phospholipids and either regulate membrane
targeting or allosterically activate GEF activity. In the case of
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655Vav1, a direct effect of phosphoinositides on exchange activity
in solution has been suggested, with activity enhanced in
response to the binding of phosphatidylinositol (4,5)-bisphosphate
(PtdIns(3,4)P2) or PtdIns(3,4,5)P3 and inhibited following the
binding of PtdIns(4,5)P2 (Han et al, 1998; Das et al, 2000). It
has been proposed that PtdIns(4,5)P2 might promote association
between the PH and DH domains, resulting in occlusion of
the GTPase-binding site, whereas binding of PtdIns(3,4)P2 or
PtdIns(3,4,5)P3 would cause dissociation of the domains and
hence increase GEF activity.
C1 domains are present in a wide range of signalling proteins
and can be divided into typical C1 domains, which bind to lipids
and regulate membrane association, and atypical C1 domains,
which lack the features required for lipid binding and instead
might be involved in protein–protein interactions (Colon-Gonzalez
& Kazanietz, 2006). On the basis of its sequence, the C1 domain
of Vav1 has been classified as atypical, which is supported by the
observation that it does not interact with phorbol esters (Kazanietz
et al, 1994). Instead, the C1 domain of the Vav family of GEFs has
been proposed to be important for enzymatic activity. Mutations
in the C1 domain reduce GEF activity, and this has been suggested
to be due to direct interactions between the C1 domain and the
GTPase (Booden et al, 2002; Zugaza et al, 2002; Heo et al, 2005).
Finally, the inhibition of GEF activity by the CH domain might be
dependent on its ability to interact with the C1 domain.
To understand the contribution of the PH and C1 domains to
the GEF activity of Vav1, and to shed light on its substrate
specificity, we determined a high-resolution X-ray structure of the
DH–PH–C1 domains of Vav1 in complex with Rac1. We show
that the PH and C1 domains contribute to efficient GEF activity by
stabilizing the DH domain structure and not through direct
contacts with the GTPase. We also report that Vav1 is a GEF for
Rac1, RhoA and Cdc42, and interpret this promiscuity in the light
of the three-dimensional structure.
RESULTS AND DISCUSSION
Overall structure of Vav1 bound to Rac1
Vav1 (amino acids (aa) 170–575) and Rac1 were coexpressed and
the nucleotide-free complex was purified by affinity and gel
filtration chromatography. The complex crystallized readily and
the structure was solved at 1.85A ˚ resolution by molecular
replacement. The overall architecture of the GTPase/DH–PH
portion of this complex is similar to that of other GTPase–GEF
complexes except for the orientation of the PH domain, which
differs extensively from structure to structure (Fig 1B). This is in
part due to significant differences in the length and orientation of
the C-terminal helix a6 of the DH domain. Interestingly, the
orientation of this helix is similar between all structurally
characterized DH domains up to a position equivalent to residue
Arg375 in Vav1, which marks the predicted C-terminal end of the
DH domain. However, in a subset of GEFs, including Vav1, this
helix is extended and often contains a slight kink around this
position, which, in turn, determines the orientation of the PH
domain. In contrast to all other RhoGEF structures reported, the
Vav1 structure presented here is the first complex to contain
another regulatory domain, the C1 domain that makes direct
contacts with the DH domain. Strikingly, the interface between
the DH and the PH–C1 cassette is extensive and buries 1,726A ˚ 2 of
solvent-accessible surface between the two domains (Fig 1B).
The Vav1–Rac1 interface
Complex formation between Rac1 and Vav1 buries about
2,600A ˚ 2 of solvent-accessible surface between them. The inter-
face is similar to that of other GTPase/DH–PH structures and, not
surprisingly, the conformations of the two switch regions super-
impose well with those of other GTPases, indicating that the
mechanism of nucleotide exchange is conserved in Vav1 (Erickson
& Cerione, 2004; Rossman et al, 2005). The structure of switch I
is supported by interactions of Glu201Vav1, a residue highly
conserved in RhoGEFs, with the hydroxyl group of Tyr32Rac1 and
the backbone amides of Thr35Rac1 and Val36Rac1. Similarly, the
backbone carbonyl of Ala59Rac1 forms a hydrogen bond with
the side chain of highly conserved Lys335Vav1 to remodel the
conformation of switch II. This is further supported by a hydrogen
bond from the side chain of His337Vav1 to the backbone oxygen
of Gly60Rac1. As seen in other GTPase–GEF complexes, the effect
of the conformational changes induced in switch I and II is to
disrupt binding to the nucleotide and Mg2þ ion, and thereby
promote nucleotide release. One of the main differences to other
structures is the lack of significant contacts between the DH
domain and strands b2 and b3 of the GTPase, which are often
present and are believed to contribute to GTPase specificity.
Residues Asp65Rac1 and Arg66Rac1 in the switch II region are the
most intimately involved residues in the Rac1–Vav1 interface and
form a total of seven hydrogen bonds with helix a6 of the DH
domain, including the side chains of Asn371Vav1, Lys374Vav1,
Arg375Vav1 and Glu 378Vav1 (Fig 2A). Some of these interactions,
such as those made by Asn371Vav1 and Glu378Vav1, are also
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Fig 1 |Overall structure of the Rac1–Vav1 DH–PH–C1 complex.
(A) Diagram showing the domain structure of Vav1. The DH–PH–C1
fragment is shown in the same colours as used throughout the
manuscript. The domain boundaries as determined by Prosite
(http://www.expasy.ch/prosite/) are indicated. (B) Ribbon diagram
of the Rac1–Vav1 DH–PH–C1 structure, with Rac1 coloured in grey,
the DH domain in cyan, the PH domain in yellow and the C1 domain
in orange. The two Zn2þ ions bound to the C1 domain are shown as
grey spheres. Ac, acidic; CH, calponin homology; DH, Dbl homology;
PH, pleckstrin homology.
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656observed in many other GTPase–GEF structures, whereas others,
especially those contributed by Lys374Vav1, are absent in most
complexes. Interestingly, in those GEFs in which the PH domain is
in direct contact with the GTPase such as Dbs, Trio or LARG,
some of the contacts with Asp65Rac1 and Arg66Rac1 are made by
residues from the PH domain, and loss of these interactions often
impairs nucleotide exchange, indicating that they are important
for the stabilization of a catalytically active conformation (Rossman
et al, 2002; Kristelly et al, 2004; Chhatriwala et al, 2007).
There have been conflicting reports on the substrate specificity
of the Vav family of proteins. In particular, the ability of Vav
proteins to be active on Cdc42 has been questioned, and it has
been suggested that different Vav isoforms have different GTPase
specificities (Schuebel et al, 1998; Aghazadeh et al, 2000; Movilla
et al, 2001). By using two different DH–PH–C1 fragments of Vav1
(‘active’ (aa 189–575) and ‘autoinhibited’ (aa 170–575)), we found
that although Rac1 is the preferred substrate of Vav1, nucleotide
exchange on Cdc42 and RhoA is also enhanced, but to a lesser
extent (Fig 2B,C; Table 1). A similar selectivity has been previously
established for Vav2 (Abe et al, 2000; Heo et al, 2005). The
structure shows that the residues of Vav1 that make contacts with
Rac1 are conserved between all human and mouse Vav isoforms,
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Fig 2 |The Rac1–Vav1 interaction and nucleotide exchange. (A) Detailed view of the interface between Asp65 and Arg66 in the switch II region of
Rac1, and residues from helix a6 of the DH domain. Atoms are coloured by type except carbons, which are the same colour as in Fig 1B. The dashed
lines indicate hydrogen bonds. Nucleotide exchange activity of (B) active (amino acids (aa) 189–575) and (C) autoinhibited (aa 170–575) Vav1
DH–PH–C1 and the isolated DH domain (aa 190–400) towards Rac1, Cdc42 and RhoA, as well as intrinsic exchange rates. DH, Dbl homology;
PH, pleckstrin homology.
Table 1|Intrinsic and Vav1-stimulated nucleotide exchange rates
Vav1 GTPase Exchange
rate (s 1)
Enhancement
over intrinsic
rate
– Rac1 0.00015 –
DH Rac1 0.0003 2
DH–PH–C1 I Rac1 0.0152 101
DH–PH–C1 A Rac1 0.117 780
– Cdc42 0.00013 –
DH–PH–C1 I Cdc42 0.0014 11
DH–PH–C1 A Cdc42 0.0072 55
– RhoA 0.0003 –
DH–PH–C1 I RhoA 0.0014 5
DH–PH–C1 A RhoA 0.019 63
The table lists rates of nucleotide exchange on Rac1, Cdc42 and RhoA (at 0.4mM)
either alone or in the presence of the following Vav1 fragments (at 1.6mM): DH
domain alone (amino acids (aa) 190–400) or DH–PH–C1 fragments containing aa
170–575 indicated by I for autoinhibited or aa 189–575 indicated by A for active.
DH, Dbl homology; PH, pleckstrin homology.
Structure of Vav1–Rac1 complex
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specificity, which is in contrast to previous suggestions (Movilla &
Bustelo, 1999; Movilla et al, 2001). Inspection of the interface
shows that there are no residues in Vav1 that would be expected
to obviously discriminate against Cdc42 or RhoA through steric
clashes. For some GEFs, discrimination between Rac1 and Cdc42
has been shown to depend on Trp56Rac1 and the equivalent
Phe56Cdc42 (Karnoub et al, 2001; Snyder et al, 2002). In Rac1-
specific GEFs such as Tiam1, conserved Ile1187 allows binding of
the bulky indole group of Trp56Rac1. Conversely, the equivalent
Leu1376 in the Cdc42-specific GEF Intersectin (Itsn) will
accommodate the smaller Phe56Cdc42 but not Trp56Rac1.I n
Vav1 the analogous residue is a methionine, Met327, whereas in
Vav2 and Vav3 it is a valine, and both the residues provide
sufficient space to accommodate a bulky tryptophan.
Interactions between DH, PH and C1 domains
In principle, DH domains contain all the residues that are required
for the remodelling of switch regions and nucleotide exchange.
Nevertheless, there are many examples of GEFs that show
enhanced exchange activity in the presence of a PH domain. In
some GEFs, there are direct contacts between the PH domain and
GTPase, and mutation of the residues involved can severely
interfere with catalysis. In the case of Vav1, the C1 domain has
been shown to be required for exchange activity and has been
proposed to make direct contacts with the GTPase (Booden et al,
2002; Zugaza et al, 2002; Heo et al, 2005). To evaluate the
importance of the PH and C1 domains in enzymatic activity, we
compared the catalytic rates of DH–PH–C1 fragments with the
isolated DH domain. Addition of the PH and C1 domains
significantly increased the activity of the DH domain (Fig 2B,C;
Table 1). However, our structure shows unequivocally that there
are no direct contacts between the PH or C1 domain and the
GTPase (Fig 1B), and thus these domains must contribute to
activity by other means. We note that the PH and C1 domains
make extensive contacts with the DH domain (Fig 3). Further-
more, the PH and C1 domains and the linker bridging the two
domains form an extensive interface, explaining why it has not
been possible to produce either an isolated domain or the DH–PH
construct in a soluble form, as these would probably expose
hydrophobic surfaces. The crucial residues in this interface are
Asp365 and Asp376 located in helix a6 of the DH domain,
Arg402 at the beginning of the PH domain and Phe540 in the
C1 domain. Asp365 contacts the side chain of Arg537 and
the backbone amide of Leu535. Asp376 and Arg402 are involved
in an extensive hydrogen-bonding network that connects the
PH and C1 domains, whereas Phe540 is at the centre of a
hydrophobic pocket formed by all three domains (Fig 3). To
examine the contribution of these interdomain interactions to
catalytic activity, we introduced the following single amino-acid
substitutions into both active (aa 189–575) and autoinhibited
(aa 170–575) Vav1: D365A, D376A, R402A and F540A.
However, introduction of these mutations severely decreased
protein stability, making it impossible to produce sufficient
quantities of pure and non-aggregated protein for exchange
assays. This observation supports the idea that an intimate DH,
PH and C1 domain interface is crucial for the structural integrity of
the DH–PH–C1 cassette.
On the basis of the structure presented here, we propose that
the PH and C1 domains contribute to GEF activity by forming a
single structural unit that binds to the critical helix a6 of the DH
domain and thereby restricts its conformational flexibility. This
Tyr 541 Phe 540
Asp 376
Arg 402
PH domain
Tyr544
Lys555
C1 domain
Leu 535
Arg537
Asp 365
DH domain
Fig 3 |The DH–PH–C1 interface. Detailed view of the interface between residues from helix a6 of the DH domain and the PH and C1 domains.
The positions of residues Gln542, Tyr544 and Lys555 within the C1 domain that have been discussed in the text are indicated. DH, Dbl homology;
PH, pleckstrin homology.
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658helix, in turn, makes crucial contacts with the switch II region to
remodel it and interfere with the binding of the Mg2þ ion. Similar
stabilizing interactions in other GEFs are provided by direct
PH–GTPase contacts, which might help to ‘lock down’ and
stabilize helix a6. The observation that in some GEFs such as Itsn
there is no obvious beneficial effect of the PH domain on
exchange activity (Pruitt et al, 2003) suggests that in those GEFs
helix a6 is either intrinsically much more rigid or that the PH
domain requires other factors such as membrane-bound lipids or
other proteins to adopt the catalytically fully active conformation.
In this respect, it is interesting to note that the DH–PH unit in
RhoGEFs is often flexible and that for some GEFs the orientation of
the PH domain in the unbound structure is different from that in
the GTPase-bound structure. By contrast, we believe that the
orientation of the PH–C1 unit observed in our structure might
constitute the conformation that will be found in both the active
and inactive states, as the interface between the DH, PH and C1
domains is so extensive that it might be energetically unfavourable
to disrupt. This model of a structural unit formed by the PH and C1
domains that stabilizes and fixes the DH domain is supported by
mutagenesis of the C1 domain, which identified three mutations
that abolished Vav1 GEF activity: Q542A, Y544A and K555A
(Zugaza et al, 2002). Gln542 probably has a structural role but
Tyr544 and Lys555 form hydrogen bonds across the PH–C1
interface to stabilize the observed domain arrangement, and thus
explain why mutation of these residues abolishes GEF activity
(Fig 3). By contrast, the structure presented here is not compatible
with previous reports suggesting a direct interaction between Rac1
and the C1 domain, which were based on nuclear magnetic
resonance (NMR) chemical shift mapping and glutathione-
S-transferase (GST) pull-down experiments (Movilla & Bustelo,
1999; Heo et al, 2005). Instead, our structure shows that the C1
domain is a long way from Rac1, and is engaged in extensive
contacts with the DH and PH domains. Our results are supported
by a recent study that also failed to detect a direct GTPase–C1
interaction (Brooun et al, 2007). The discrepancy between these
studies might be due to the tendency of the isolated C1 domain to
aggregate, and thus the reported GTPase–C1 contacts might be
nonspecific interactions.
Ligand-binding properties of the PH and C1 domains
Binding of phosphoinositides to the PH domain of Vav1 has been
proposed to allosterically regulate GEF activity by modulating
interactions between the PH and DH domains (Han et al, 1998;
Das et al, 2000). However, our structure does not provide support
for such a model, as the phosphoinositide-binding site is located
away from the interface with the DH domain (supplementary
Figs S1,S2 online). Furthermore, given the extensive interactions
made between the DH domain and the PH–C1 module, it seems
unlikely that this module would undergo major conformational
changes before GTPase binding. In agreement with this, Bustelo
and co-workers (Zugaza et al, 2002) could not detect an effect of
phospholipids on Vav1 activity in vitro. Nonetheless, our structure
does not preclude the possibility that phospholipid binding to the
PH domain might regulate membrane targeting of Vav1.
The C1 domain of Vav1 belongs to the group of atypical C1
domains that do not bind to diacylglycerol (DAG) or phorbol ester
(Kazanietz et al, 1994; Colon-Gonzalez & Kazanietz, 2006). In
spite of this, its structure overlaps well with that of the typical
protein kinase Cd (PKCd) C1 domain, bound to phorbol-13-acetate
(46 atoms overlap with an r.m.s.d. of 0.9A ˚; Fig 4A; Zhang et al,
1995). In particular, the loops making up the ligand-binding site in
PKCd are conserved in Vav1, in contrast to the structures of the
atypical C1 domains of, for example, Raf1 (Mott et al, 1996;
Fig 4A). Furthermore, Vav1 contains a solvent-exposed cavity in
the same position in which phorbol-13-acetate is bound to
PKCd (Fig 4B) and that is flanked on one side by hydrophobic
residues from helix a6 of the DH domain, indicating that it
could accommodate a small molecule (Fig 4C). Intriguingly, this
potential ligand-binding site is located next to the region in the a6
helix that makes contacts with switch II of Rac1, suggesting that
ligand binding to the C1 domain could modulate Vav1 activity.
Further studies are now required to identify such a putative ligand
and to test this model.
Vav1 activation
Nucleotide exchange activity of Vav1 is regulated through an
intricate interplay between reversible phosphorylation, auto-
inhibitory protein interactions and possibly lipid binding. The NMR
structure of an autoinhibited DH fragment explained how the
region containing Tyr174 inhibits exchange activity by occluding
part of the GTPase-binding site (Aghazadeh et al, 2000). However,
the observation that we were able to purify a complex of Rac1 and
Arg 66
AC
B
Fig 4 |The C1 domain of Vav1. (A) Overlap of the C1 domain of Vav1
(orange) with that of the typical C1 domain of PKCd bound to
phorbol-13-acetate (1PTR, blue) and the atypical C1 domain of Raf1
(1FAR, green). The ligand bound to PKCd is shown in a ball-and-stick
representation. (B) Surface representation of the C1 domain of PKCd with
bound phorbol acetate. (C) Surface representation of Vav1 DH–PH–C1
shows a pocket in the C1 domain in the same position in which phorbol
acetate is bound to PKCd (shown for comparison). DH, Dbl homology;
PH, pleckstrin homology; PKCd, protein kinase Cd.
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exchange assays, indicates that autoinhibitory interactions made
by the Tyr174-containing helix are not sufficient on their own to
maintain the inactive state. Instead, open and closed conforma-
tions seem to be in a dynamic equilibrium that can easily be
shifted towards the open conformation in the presence of Rac1.
Hence, other in vivo mechanisms for successful repression are
crucial. These are believed to involve intramolecular interactions
between the CH and C1 domains. So far, structural information
that could confirm such a mechanism is limited to the low-
resolution electron microscopic structure of Vav3 (Llorca et al,
2005). This study compared the structures of full-length inactive,
full-length phosphorylated and N-terminally truncated Vav3. The
structure most relevant to the complex presented here is that of the
truncated protein. A distinguishing characteristic of the recon-
structed model is the position of the DH and C1 domains, which
are suggested to occupy opposite sides of the PH domain and do
not form any contacts. The structure presented here clearly shows
that this is not correct, but now provides the opportunity to
reinterpret the electron microscopic data by fitting the structure
presented here into the overall protein envelope.
CONCLUSION
Here, we have made a first step towards an understanding of how
regulatory domains in RhoGEFs outside the DH–PH module can
contribute to the regulation of enzymatic activity. In addition, our
structure has highlighted the existence of a putative ligand-binding
pocket located at the C1–DH domain interface in a location
where ligand binding could possibly modulate the exchange
activity of Vav1 and its isoforms.
METHODS
The fragments of Vav1 used for nucleotide exchange assays were
expressed in BL21-AI cells with an N-terminal His6 tag, and then
purified by affinity and gel filtration chromatography. The
Rac1–Vav1 complex used for crystallization was produced by
coexpression of Vav1 with GST-Rac1 and purification by affinity
chromatography, followed by thrombin cleavage of the GST tag
and gel filtration.
The Rac1–Vav1 complex was crystallized in hanging drops
containing equal amounts of complex at 12mg/ml and well
solution (100mM Bicine pH 9.0, 10% PEG6000). Crystals were
cryoprotected with PEG400 and data were collected at SRS
Daresbury. The structure was solved by molecular replacement
using the Vav1-DH domain and Rac1 as search models.
Refinement was carried out in REFMAC/ARP and model
building in COOT. The final model of the complex has an
R-factor of 20.6% (Rfree 25.2%). The structural data have been
deposited in the Protein Data Bank database, with the accession
code 2vrw.pdb.
Guanine nucleotide exchange assays were carried out by
fluorescence spectroscopy using N-methylanthraniloyl-GDP-
labelled GTPases. Exchange was monitored by following fluores-
cence emission of the mant-labelled GTPase (400nM) in the
presence of 1.6mM GEF together with 2mM unlabelled GDP
(using an ISS PC1 fluorimeter) at lex¼360nm and lem¼440nm.
For detailed descriptions, see the supplementary information online.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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